Welcome to our dedicated page for AdaptHealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on AdaptHealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a leading provider of patient-centered, healthcare-at-home solutions across the United States. Operating in 47 states, AdaptHealth offers a comprehensive range of home medical equipment (HME) and services to help patients manage chronic conditions and improve their quality of life in the comfort of their homes.
Founded on the principle that everyone deserves a comfortable and independent life, AdaptHealth's offerings include sleep and respiratory therapy, diabetes management supplies, mobility products, wound care, non-invasive ventilation, and nutritional support. Their clinically-focused services assist patients with daily living activities, supporting approximately 4.1 million patients annually through a network of around 670 locations.
The company's core offerings include sleep therapy equipment (including CPAP and biPAP services) for those with obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and oxygen therapy and related chronic care services. Additionally, AdaptHealth provides specialized HME devices and supplies for wound care, urological, incontinence, ostomy, and nutritional needs.
AdaptHealth is renowned for its extensive partnerships with a diverse network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors, making it a cornerstone in the provision of at-home medical care in the U.S.
Despite facing challenges, AdaptHealth has shown remarkable financial resilience and growth. The company reported a net revenue of $793.3 million for the second quarter of 2023, an increase of 9% compared to the same period in 2022. Their adjusted EBITDA reached $171.0 million, up by 14%, showcasing robust financial health and operational efficiency.
Going forward, AdaptHealth continues to focus on enhancing its service offerings and operational efficiency under new leadership. The recent appointment of Suzanne Foster as Chief Executive Officer marks a significant step in the company’s strategic direction, aimed at furthering its mission to deliver high-quality, patient-centered care.
For more detailed financial results and updates, visit AdaptHealth’s official website.
AdaptHealth Corp. (NASDAQ: AHCO) announced its participation in the Canaccord Genuity 44th Annual Growth Conference on August 14, 2024, in Boston. The company will present a fireside chat at 1:30 pm ET, with a webcast link available on its website under 'Investor Relations'.
AdaptHealth is a leading provider of patient-centered, healthcare-at-home solutions, including home medical equipment and supplies. Their offerings include sleep therapy equipment like CPAP and biPAP services, diabetes treatment devices such as continuous glucose monitors and insulin pumps, and various medical supplies for chronic conditions. They serve approximately 4.1 million patients annually across all 50 states with a network of roughly 680 locations in 47 states.
View the full press release on BusinessWire.
AdaptHealth Corp. (NASDAQ: AHCO) reported its Q2 2024 financial results, showing mixed performance. Net revenue increased by 1.6% to $806.0 million, while net income rose 39.0% to $19.4 million. However, Adjusted EBITDA decreased by 3.3% to $165.3 million. The company's cash flow from operations improved to $247.0 million year-to-date, with free cash flow reaching $77.9 million.
AdaptHealth updated its fiscal year 2024 guidance, adjusting net revenue to $3.255-$3.315 billion, maintaining Adjusted EBITDA at $660-$700 million, and increasing free cash flow to $160-$180 million. The company also announced plans to dispose of certain non-core assets in Q3 2024.
AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, has announced its second quarter 2024 earnings release date and conference call details. The company will release its financial results on Tuesday, August 6, 2024, before the financial markets open. A teleconference for analysts and investors will be held at 8:30 a.m. ET on the same day.
Interested parties can participate in the call by dialing (800) 343-4136 (Domestic) or (203) 518-9843 (International) and referencing Conference ID: AHCO2Q24. A webcast registration link is also provided. Following the live call, a replay will be available for six months on the company's website under the 'Investor Relations' section.
AdaptHealth Corp. (NASDAQ: AHCO) has announced significant changes to its board of directors and management. Dale Wolf has been appointed as Chair of the Board of Directors effective July 1, 2024, succeeding Richard Barasch. Dale Wolf has been a board member since November 2019. Additionally, CEO Suzanne Foster has joined the Board effective May 20, 2024. President Josh Parnes will step down from his role on August 31, 2024, and from the Board on December 31, 2024.
AdaptHealth specializes in providing home medical equipment, supplies, and related services, reaching approximately 4.1 million patients across the U.S. annually through its extensive network.
AdaptHealth Corp. (NASDAQ: AHCO) announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024. AdaptHealth, a leader in providing patient-centered, healthcare-at-home solutions, will present at 9:20am ET. The company offers a comprehensive range of medical products and services, including sleep therapy equipment, diabetes treatment devices, home medical equipment, and chronic therapy services. AdaptHealth serves about 4.1 million patients annually through 680 locations in 47 states, partnering with a diverse network of referral sources like hospitals and clinics.
AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of healthcare-at-home solutions, announced its participation in the Jefferies Global Healthcare Conference in New York on June 5, 2024. The event will include a fireside chat at 4:00 pm ET, accessible via webcast on the company's website. AdaptHealth offers a comprehensive range of home medical equipment and services, including sleep therapy, diabetes treatment, and chronic condition management. The company serves around 4.1 million patients annually across all 50 states through a network of 680 locations in 47 states. Further details can be found on their investor relations page.
AdaptHealth Corp. (NASDAQ: AHCO), a leader in healthcare-at-home solutions, announced its participation in the UBS Healthcare Services Cape Cod Summit on June 4, 2024. AdaptHealth provides a range of home medical equipment and services, including sleep therapy, diabetes treatment, and chronic therapy services. The company supports 4.1 million patients annually in all 50 states through a network of 680 locations in 47 states. AdaptHealth partners with a diverse network of referral sources such as hospitals, clinics, and skilled nursing facilities.
AdaptHealth Corp. (NASDAQ: AHCO) announced the grant of restricted stock units (RSUs) to Suzanne Foster, the newly appointed CEO, as an inducement under Nasdaq Listing Rule 5635(c)(4). The grant, approved by the Compensation Committee on May 11, 2024, covers 553,251 shares of common stock at target performance levels. The RSUs vest in three tranches: 229,740 shares over three years starting May 20, 2025, 93,771 shares over two years starting the same date, and the remaining shares based on the Total Shareholder Return (TSR) over a three-year period. The vesting depends on Ms. Foster's continued service with AdaptHealth. The company provides home medical equipment and services, reaching 4.1 million patients annually across 670 locations in 47 states.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in the 2024 Leerink Partners Healthcare Crossroads Conference in Austin on May 29, 2024, with a fireside chat at 3:00 PM CT. AdaptHealth is a national provider of patient-centered healthcare-at-home solutions, including home medical equipment, supplies, and related services. Their services cater to patients with chronic conditions, offering sleep therapy equipment, diabetes treatment devices, and other home medical equipment. The company reaches approximately 4.1 million patients annually across all 50 states through 680 locations in 47 states. A webcast link for the event will be available on the company's website under 'Investor Relations'.
AdaptHealth Corp. will participate in the BofA Securities 2024 Health Care Conference, with key executives engaging in a fireside chat. The Company offers patient-centered healthcare-at-home solutions, catering to over 4.1 million patients annually in all 50 states. AdaptHealth provides a wide range of medical products and services, including sleep therapy equipment, diabetes treatment supplies, HME devices, oxygen therapy, and other related services.
FAQ
What is the current stock price of AdaptHealth (AHCO)?
What is the market cap of AdaptHealth (AHCO)?
What services does AdaptHealth Corp. provide?
Where does AdaptHealth operate?
What is included in AdaptHealth’s sleep therapy services?
How does AdaptHealth assist patients with diabetes?
What recent financial performance has AdaptHealth reported?
Who is the current CEO of AdaptHealth Corp.?
What kind of equipment does AdaptHealth provide for respiratory therapy?
How does AdaptHealth support wound care?
What partnerships does AdaptHealth have?
How can investors get more information about AdaptHealth?
